The study for the effects of Lactiplantibacillus plantarum 22A-3 on muscle soreness

UMIN ID: UMIN000055376

Registered date:02/09/2024

Basic Information

• Recruitment status: Complete: follow-up continuing
• Health condition(s) or Problem(s) studied: Healthy volunteer
• Date of first enrollment: 2024/09/03
• Target sample size: 12
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Take test food(with Lactiplantibacillus plantarum 22A-3)for 22 days(1 capsule per day). After muscle soreness is induced, manual therapy on one upper limb.
Take test food (with Lactiplantibacillus plantarum 22A-3)for 22 days (1 capsule per day). After muscle soreness is induced, without manual therapy on the other upper limb as control.
Take placebo food (without Lactiplantibacillus plantarum 22A-3)for 22days (1 capsule per day). After muscle soreness is induced, manual therapy on one upper limb.
Take placebo food (without Lactiplantibacillus plantarum 22A-3)for 22days (1 capsule per day). After muscle soreness is induced, without manual therapy on the other upper limb as control.

Outcome(s)

• Primary Outcome: 1.Elbow flexor /extension range of motion, /angular velocity (rad/s) 2.Pain assessment (pressure pain, concentric contraction, and eccentric contraction) 3.Muscle hardness 4.Sliding assessment 5 Elbow flexor maximal isometric strength (Nm)

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: 30years-old
• Gender: Male
• Exclude criteria: (1)Subjects who have a medical history or present illness of an Orthopedic Diseases on the upper limbs (2)Subjects who continuously perform exercises using the upper limbs for at least one hour once a week (3)Subject who have an allergy for test food

Related Information

• Primary Sponsor: Toin University of Yokohama
• Source(s) of Monetary Support: JAPAN SPORT COUNCIL